Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
18
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
21
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
19
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Melrose Industries
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Decarbonization And Digitalization Will Accelerate Global Aircraft Demand
Key Takeaways Margin expansion and free cash flow growth are set to outpace consensus due to faster restructuring benefits and higher operating leverage as volumes increase. Technological leadership, strategic partnerships, and global footprint uniquely position Melrose to benefit from aviation trends, supporting sustained top-line and margin growth.
View narrative
UK£8.25
FV
29.3% undervalued
intrinsic discount
10.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 10 hours ago
author updated this narrative
Xponential Fitness
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Delayed Studio Openings Will Constrain Operations Yet Recovery Will Materialize
Key Takeaways Growing health trends and brand investments are positives, but rising digital fitness and economic uncertainty threaten membership growth and recurring revenues. Franchise expansion faces delays and brand closures, while execution risks and competition may cap earnings growth and margin expansion.
View narrative
US$9.00
FV
0.8% overvalued
intrinsic discount
2.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Voyager Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Gene Therapy Competition Will Curb Progress Yet Allow Modest Breakthroughs
Key Takeaways Heavy reliance on a small set of programs and selective partnerships increases risk, as setbacks or partner changes could sharply reduce revenue growth and licensing income. Delays from regulatory scrutiny and emerging competition in gene therapies threaten timely growth, while persistent expenses and pricing pressures could weaken profit margins.
View narrative
US$8.00
FV
58.1% undervalued
intrinsic discount
-19.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Evonik Industries
AN
AnalystHighTarget
Consensus Narrative from 13 Analysts
Circular Economy And Decarbonization Trends Will Unlock Specialty Markets
Key Takeaways Aggressive cost-saving initiatives and digital transformation are set to drive lasting margin expansion, with management guiding for significantly higher-than-expected operational efficiency gains. Strategic focus on sustainable technologies and resilient production supports robust earnings growth, with premium revenue opportunities unlocking across healthcare, nutrition, and green specialty chemicals.
View narrative
€25.00
FV
31.6% undervalued
intrinsic discount
2.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Falabella
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Expanding Latin American E-Commerce Will Boost Retail Opportunities
Key Takeaways E-commerce momentum, integrated digital ecosystems, and advanced AI initiatives are positioning Falabella for lasting margin gains and greater cross-business synergies. Exclusive brands and expanded financial services are boosting customer value and strengthening competitive advantage amid growing digital adoption in Latin America.
View narrative
CL$6.00k
FV
10.5% undervalued
intrinsic discount
7.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Montauk Renewables
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
EPA Cuts And Oversupply Will Depress RNG Market Outlook
Key Takeaways Structural shifts in regulation and policy threaten Montauk's core revenue streams by reducing demand and tightening credit eligibility for renewable natural gas. Rising competition, elevated costs, and alternative renewables undercut margin growth and strategic relevance, risking sustained declines in profitability and sector positioning.
View narrative
US$1.50
FV
32.7% overvalued
intrinsic discount
16.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Reservoir Media
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Steep Costs And Debt Will Strain Catalogs But Resilience Awaits
Key Takeaways Elevated acquisition costs and tighter credit may limit growth via catalog purchases, making revenue expansion and earnings scaling through M&A more challenging. Regulatory uncertainties and industry consolidation threaten royalty rates, while reliance on acquisitions exposes the company to heightened competition and fragmented media consumption trends.
View narrative
US$11.50
FV
32.7% undervalued
intrinsic discount
4.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Franklin Covey
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Regulatory Pressures Will Limit Expansion Though Resilience Will Shine
Key Takeaways Increased adoption of AI and shifting buyer preferences toward analytics-driven solutions may limit high-margin services growth and make client retention more difficult. Escalating data privacy regulations, pricing pressures, and market saturation could compress margins and require costly investments to sustain international and digital expansion.
View narrative
US$27.00
FV
30.0% undervalued
intrinsic discount
2.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 10 hours ago
author updated this narrative
GEA Group
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Global Population Growth And Smart Automation Will Redefine Production
Key Takeaways Strong execution, innovative food tech investments, and adoption of digital services position GEA for accelerated growth, robust margins, and recurring revenue gains ahead of expectations. GEA's healthy balance sheet and strategic M&A potential enable it to capitalize on industry shifts, capturing outsized market share as food and pharma sectors move toward compliance-driven upgrades.
View narrative
€72.46
FV
10.9% undervalued
intrinsic discount
5.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 10 hours ago
author updated this narrative
Value any company in seconds
Popular companies